These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31673468)

  • 1. Visceral adiposity indicators as predictors of metabolic syndrome in postmenopausal women.
    Anık İlhan G; Yıldızhan B
    Turk J Obstet Gynecol; 2019 Sep; 16(3):164-168. PubMed ID: 31673468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity- and lipid-related indices as a predictor of obesity metabolic syndrome in a national cohort study.
    Gui J; Li Y; Liu H; Guo LL; Li J; Lei Y; Li X; Sun L; Yang L; Yuan T; Wang C; Zhang D; Wei H; Li J; Liu M; Hua Y; Zhang L
    Front Public Health; 2023; 11():1073824. PubMed ID: 36875382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome.
    Anik Ilhan G; Yildizhan B; Pekin T
    Gynecol Endocrinol; 2019 Mar; 35(3):233-236. PubMed ID: 30303693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LIPID ACCUMULATION PRODUCT, VISCERAL ADIPOSITY INDEX, AND CHINESE VISCERAL ADIPOSITY INDEX AS MARKERS OF CARDIOMETABOLIC RISK IN ADULT GROWTH HORMONE DEFICIENCY PATIENTS: A CROSS-SECTIONAL STUDY.
    Xie X; Li Q; Zhang L; Ren W
    Endocr Pract; 2018 Jan; 24(1):33-39. PubMed ID: 29144802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study.
    Ramezani Tehrani F; Minooee S; Azizi F
    Eur J Endocrinol; 2014 Aug; 171(2):199-207. PubMed ID: 24816947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of various body indices and visceral adiposity index in predicting metabolic syndrome among Chinese patients with adult growth hormone deficiency.
    Qing L; Wei R; Chan L; Xiaoya Z; Xin X
    J Endocrinol Invest; 2017 Jun; 40(6):653-661. PubMed ID: 28233232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Novel Biomarkers of Insulin Resistance With Homeostasis Model Assessment of Insulin Resistance, Its Correlation to Metabolic Syndrome in South Indian Population and Proposition of Population Specific Cutoffs for These Indices.
    Jog KS; Eagappan S; Santharam RK; Subbiah S
    Cureus; 2023 Jan; 15(1):e33653. PubMed ID: 36788883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of eight insulin resistance surrogate indexes for predicting metabolic syndrome and hypertension in Thai law enforcement officers.
    Rattanatham R; Tangpong J; Chatatikun M; Sun D; Kawakami F; Imai M; Klangbud WK
    PeerJ; 2023; 11():e15463. PubMed ID: 37273533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid Accumulation Product Better Predicts Metabolic Status in Lean Polycystic Ovary Syndrome than that by Visceral Adiposity Index.
    Banu H; Morshed MS; Sultana T; Shah S; Afrine S; Hasanat MA
    J Hum Reprod Sci; 2022; 15(1):27-33. PubMed ID: 35494190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral Adiposity Index, Triglyceride/High-Density Lipoprotein Ratio, and Lipid Accumulation Product Index to Discriminate Metabolic Syndrome Among Adult Type 1 Diabetes Patients.
    Karatas S; Beysel S
    Metab Syndr Relat Disord; 2021 Nov; 19(9):507-512. PubMed ID: 34283922
    [No Abstract]   [Full Text] [Related]  

  • 11. Gender Differences in the Relationships among Metabolic Syndrome and Various Obesity-Related Indices with Nonalcoholic Fatty Liver Disease in a Taiwanese Population.
    Lin IT; Lee MY; Wang CW; Wu DW; Chen SC
    Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33498329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance using obesity and lipid-related indices and atherogenic index of plasma to predict metabolic syndrome in the adult sudanese population.
    Mosad AS; Elfadil GA; Elhassan SH; Elbashir ZA; S A Husain NEO; Karar T; Elfaki EM
    Niger J Clin Pract; 2023 May; 26(5):617-624. PubMed ID: 37357479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting metabolic syndrome by obesity- and lipid-related indices in mid-aged and elderly Chinese: a population-based cross-sectional study.
    Li Y; Gui J; Liu H; Guo LL; Li J; Lei Y; Li X; Sun L; Yang L; Yuan T; Wang C; Zhang D; Wei H; Li J; Liu M; Hua Y; Zhang L
    Front Endocrinol (Lausanne); 2023; 14():1201132. PubMed ID: 37576971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance.
    Mazidi M; Kengne AP; Katsiki N; Mikhailidis DP; Banach M
    J Diabetes Complications; 2018 Mar; 32(3):266-270. PubMed ID: 29395839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral Adiposity Index (VAI) in Children and Adolescents with Obesity: No Association with Daily Energy Intake but Promising Tool to Identify Metabolic Syndrome (MetS).
    Vizzuso S; Del Torto A; Dilillo D; Calcaterra V; Di Profio E; Leone A; Gilardini L; Bertoli S; Battezzati A; Zuccotti GV; Verduci E
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33525454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of visceral, general and central obesity indices in the prediction of metabolic syndrome in maintenance hemodialysis patients.
    Zhou C; Zhan L; Yuan J; Tong X; Peng Y; Zha Y
    Eat Weight Disord; 2020 Jun; 25(3):727-734. PubMed ID: 30968371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between metabolic syndrome, serum thyrotropin, and thyroid antibodies status in postmenopausal women, and the role of interleukin-6.
    Siemińska L; Wojciechowska C; Walczak K; Borowski A; Marek B; Nowak M; Kajdaniuk D; Foltyn W; Kos-Kudła B
    Endokrynol Pol; 2015; 66(5):394-403. PubMed ID: 26457493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proportional correlates of cystatin-C with pentraxin-3, visceral adiposity index and atherogenicity index of plasma but not blood indices in metabolic syndrome patients with and without prediabetes.
    Al-Batsh MMW; Albsoul-Younes A; Kasabri V; Suyagh M; Alalawi S; Yasin N
    Horm Mol Biol Clin Investig; 2018 Nov; 36(3):. PubMed ID: 30496135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Metabolic Score for Visceral Fat (METS-VF) a Better Index Than Other Adiposity Indices for the Prediction of Visceral Adiposity.
    Torun C; Ankaralı H; Caştur L; Uzunlulu M; Erbakan AN; Akbaş MM; Gündüz N; Doğan MB; Oğuz A
    Diabetes Metab Syndr Obes; 2023; 16():2605-2615. PubMed ID: 37663201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Individuals.
    Er LK; Wu S; Chou HH; Hsu LA; Teng MS; Sun YC; Ko YL
    PLoS One; 2016; 11(3):e0149731. PubMed ID: 26930652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.